Nasal polyposis (NP) is a chronic paranasal sinuses inflamma-tory disease causing severe nasal and systemic symptoms includingfatigue, sleeping problems, and impairments in social, emotionaland lifestyle conditions. Patients with severe eosinophilic asthma (SEA) have frequent comorbid NP, which may impact asthma severity
Severe eosinophilic asthma (SEA) is associated with high peripheral blood and airway eosinophilia, r...
Background: Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the t...
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) affects around 60% of patients with se...
Nasal polyposis (NP) is a chronic paranasal sinuses inflamma-tory disease causing severe nasal and s...
Background/aim: Oral corticosteroid (OCS)-dependent severe eosinophilic asthma with chronic rhinosin...
Background: Severe eosinophilic asthma is frequently associated to chronic rhinosinusitis and nasal ...
The aim of this study was to evaluate the efficacy of mepolizumab in patients affected by chronic rh...
Background: The efficacy of mepolizumab has been largely demonstrated in clinical trials in patients...
Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic...
Mepolizumab (MEP) has been recently introduced to treat severe eosinophilic asthma. Trials have demo...
The efficacy of mepolizumab is well documented in severe eosinophilic asthma (SEA), although the str...
Background: In the phase III SYNAPSE study, mepolizumab reduced nasal polyp (NP) size and nasal obst...
Severe eosinophilic asthma (SEA) is associated with high peripheral blood and airway eosinophilia, r...
Severe eosinophilic asthma (SEA) is associated with high peripheral blood and airway eosinophilia, r...
Background: Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the t...
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) affects around 60% of patients with se...
Nasal polyposis (NP) is a chronic paranasal sinuses inflamma-tory disease causing severe nasal and s...
Background/aim: Oral corticosteroid (OCS)-dependent severe eosinophilic asthma with chronic rhinosin...
Background: Severe eosinophilic asthma is frequently associated to chronic rhinosinusitis and nasal ...
The aim of this study was to evaluate the efficacy of mepolizumab in patients affected by chronic rh...
Background: The efficacy of mepolizumab has been largely demonstrated in clinical trials in patients...
Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic...
Mepolizumab (MEP) has been recently introduced to treat severe eosinophilic asthma. Trials have demo...
The efficacy of mepolizumab is well documented in severe eosinophilic asthma (SEA), although the str...
Background: In the phase III SYNAPSE study, mepolizumab reduced nasal polyp (NP) size and nasal obst...
Severe eosinophilic asthma (SEA) is associated with high peripheral blood and airway eosinophilia, r...
Severe eosinophilic asthma (SEA) is associated with high peripheral blood and airway eosinophilia, r...
Background: Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the t...
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) affects around 60% of patients with se...